A carregar...
Fremanezumab in the treatment of migraines: evidence to date
Calcitonin gene-related peptide (CGRP) is a major player in migraine pathophysiology, and CGRP monoclonal antibodies including fremanezumab may be a safe effective preventive therapy. Phase IIb studies in episodic migraine (EM) and chronic migraine (CM) demonstrated efficacy at both the monthly 225...
Na minha lista:
| Publicado no: | J Pain Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709817/ https://ncbi.nlm.nih.gov/pubmed/31686900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S166427 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|